about
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral loadAssessing predicted HIV-1 replicative capacity in a clinical settingLong-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimensAdherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort StudyThe individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patientsPersistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgroundsA Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected PatientsCorrection: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing RegimensMinor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patientsIdentification and characterization of two closely related unclassifiable endogenous retroviruses in pythons (Python molurus and Python curtus)Induced prion protein controls immune-activated retroviruses in the mouse spleenParent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup.Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.Estimating the basic reproductive number from viral sequence data.Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.Inferring epidemic contact structure from phylogenetic trees.Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide.Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland.Direct evidence for natural transmission of small-ruminant lentiviruses of subtype A4 from goats to sheep and vice versa.An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.Gammaretrovirus-specific antibodies in free-ranging and captive Namibian cheetahs.Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infectionQuality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.HIV rebounds from latently infected cells, rather than from continuing low-level replicationGenotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in SwitzerlandTracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairsA Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland.Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV.Prevalence of human T-cell leukemia virus types I and II in Switzerland.Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing.Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.Large-scale inference of conjunctive Bayesian networks.Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase.
P50
Q28475652-28B5BC7C-235E-4D6F-9A6A-EA9F99E119A9Q28477801-678004C4-43E0-471D-8B95-B9D2D2FDCA6FQ28485321-CC9448B9-93C4-493F-BA9F-56CB89D3B5B8Q28534423-990BA136-3E40-46D9-80BE-E7930CFC0848Q28536153-806A53F2-43E2-4DB8-8E40-EF3C71CECB1FQ28544845-97B9B9E2-BFA2-4BD1-830D-BA0BAD7B9DF1Q28546535-5C1348E1-10FE-4874-AA40-39840EF453C7Q28683189-654CDBC7-64FD-4C64-9FD7-52DCFE93A83CQ28728304-A8915DC0-FB8C-4FE9-A628-2DF6EBB3DE5AQ31093723-D0D68682-F36F-4C04-A548-7AC926D989CBQ33305220-40155A2A-421B-48E6-95CD-5EC06860E040Q33722738-BA389210-F5B6-4486-88D8-E81CA89E00DAQ33883813-3A014026-D311-40E9-9E16-8B1552596666Q34010717-B18A0DA4-4677-4260-8865-79076C5B8CFBQ34109639-7BE26507-371C-497C-B0B7-B0F5632DC2FDQ34192802-14E3E2AA-0163-4D4D-900D-C65365EEF663Q34309493-E8E7D994-216F-4EA2-94A8-F4E325376A86Q34400923-D3D4B463-0EDD-4567-AA1C-D16A520FBF66Q34547116-C4ED59DE-BDB2-4698-BDC2-D76ADA63CE2FQ34662575-AB1EF4D5-8674-496E-B539-938FFAE86BC3Q34699175-FF959391-CA97-41F3-9E0A-7518D1039552Q35057734-34829A9D-3718-4E47-BEB1-811871079F72Q35093899-75C95AAA-0E91-4723-98EC-11D7885204A0Q35123481-01DCB1C4-4486-4B2A-95E5-6DABAB74675FQ35273824-9EAD70C5-8428-46C6-8A92-B01C55F6AFDEQ35656647-B3ABAC14-2BB3-4865-826D-4DC495A7D744Q36054188-6192A5DB-229B-4E0C-9929-D465D28C6507Q36380118-8E126FB9-D5B9-4150-8BE0-0B005D3ADAB2Q36747463-32550536-7DA5-439A-9D83-0394984480F2Q36954950-2516BAA1-14A5-4917-BF03-4B761620B6BDQ37000515-DACDA276-D9D7-487F-8CAC-065C89D5E4F3Q37233074-EF817B01-B3F5-44A3-85E6-6F60CA10F70FQ37264576-FA53ECC7-9632-4AA4-BF30-AE31E7CF44B4Q38422593-EB9D9CDD-B12D-4B65-96C3-6FB1E06F624BQ38449459-791C08C7-B1E4-45EE-9073-76D626986D83Q38887171-20291E28-3B69-4DB8-8815-C008B0FDE1FCQ39170603-97C9801A-A76C-4913-AE4A-224004B8DEDBQ39398170-1574D6A1-9764-4C62-A5AA-1E2B24F1532FQ39429304-2F985F4D-CA76-4C13-9428-A759FFAF6273Q39737416-637919D0-D94F-4249-A101-50BD43C9B909
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jürg Böni
@ast
Jürg Böni
@en
Jürg Böni
@es
Jürg Böni
@nl
Jürg Böni
@sl
type
label
Jürg Böni
@ast
Jürg Böni
@en
Jürg Böni
@es
Jürg Böni
@nl
Jürg Böni
@sl
prefLabel
Jürg Böni
@ast
Jürg Böni
@en
Jürg Böni
@es
Jürg Böni
@nl
Jürg Böni
@sl